Nuvation Bio NUVB Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| License | $99.87M+161% | $38.24M+115% | $17.79M+35.6% | $13.12M+19.7% | $10.96M+39.2% | |
| Product Revenue | $42.8M+70.5% | $25.1M— | —— | —— | —— | |
| Royalty Revenue | $2.2M+120% | $1M— | —— | —— | —— | |
| Revenue by Geography | ||||||
| CN | $11.7M+24.3% | $9.41M-24.3% | $12.43M+20.6% | $10.31M+28.1% | $8.05M+56.4% | |
| JP | $29.3M+1.6% | $28.83M+438% | $5.36M+90.8% | $2.81M-3.4% | $2.91M+6.7% | |
| US | $102.05M+314% | $24.66M+175% | $8.96M+624% | $1.24M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Nuvation Bio break its business down?
- Nuvation Bio (NUVB) reports revenue by product across 4 parts — License, Product Revenue, Research And Development Service Revenue and Royalty Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Nuvation Bio's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Nuvation Bio's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.